DEXCOM, INC. (DXCM) Total liabilities 2016–2025
DEXCOM, INC. (DXCM) total liabilities at each fiscal year-end, per SEC filings.
$3.6BFY2025 · since FY2016: $119.0M → $3.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.6B | -18.0% |
| FY2024 | $4.4B | +4.4% |
| FY2023 | $4.2B | +28.7% |
| FY2022 | $3.3B | +12.8% |
| FY2021 | $2.9B | +17.3% |
| FY2020 | $2.5B | +62.9% |
| FY2019 | $1.5B | +20.7% |
| FY2018 | $1.3B | +158.4% |
| FY2017 | $484.7M | +307.3% |
| FY2016 | $119.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More DXCM financial trends
DXCM RevenueDXCM Net incomeDXCM Net marginDXCM Gross profitDXCM Gross marginDXCM Operating incomeDXCM Operating marginDXCM Operating cash flowDXCM Free cash flowDXCM Capital expendituresDXCM Return on equityDXCM Stock buybacksDXCM Dividends paidDXCM Total assetsDXCM Shareholders’ equityDXCM overview →